Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3535300 Title: ANTICORPS ANTI-CTLA-4 ACTIVABLES ET LEURS UTILISATIONS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
178379178
WO application number:
US2017059740
Type:
European patent granted for BE
Status:
Open
Publication number:
3535300
WO publication number:
WO2018085555
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
02/11/2017
Grant date:
22/10/2025
EP publication date:
11/09/2019
WO publication date:
11/05/2018
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
22/10/2025
EP B1 publication date:
22/10/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
02/11/2037

Applicant

1

Name:
Bristol-Myers Squibb Company
Legal Form:
From:
22/10/2025
Address:
Route 206 and Province Line Road, Princeton, NJ 08543, United States (US)
To:

2

Name:
CytomX Therapeutics, Inc.
Legal Form:
From:
22/10/2025
Address:
151 Oyster Point Boulevard Suite 400, South San Francisco, California 94080, United States (US)
To:

Inventor

1

Name:
TIPTON, Kimberly Ann
Legal Form:
Address:
South San Francisco, California 94080, United States (US)

2

Name:
WEST, James William
Legal Form:
Address:
South San Francisco, California 94080, United States (US)

3

Name:
DESHPANDE, Shrikant
Legal Form:
Address:
Redwood City, California 94063, United States (US)

4

Name:
ENGELHARDT, John J.
Legal Form:
Address:
Redwood City, California 94063, United States (US)

Priority

Priority patent number:
201662417212 P
Priority date:
03/11/2016
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07K 16/28; A61K 39/395; C12N 15/13; C12N 15/62; C07K 19/00; A61P 35/00;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2025/20
Publication date:
11/12/2025
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202543
Publication date:
22/10/2025
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
01/06/2026
Annual fee number:
9
Annual fee amount:
165 Euro
Penalty fee amount:
85 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type